| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Javitt Daniel C. serves as a 10% Owner at NRXP. Across recent SEC filings that breaks down to 0 buys and 9 sells. Those positions are worth an estimated $14.5M at current prices.
Historically, Javitt Daniel C.'s trades have earned a strong insider score of 75/100 across 9 rated trades. Over a 12-month horizon, 88.9% of those trades were profitable, with an average 12-month return of +48.4%.
The biggest single holding is NRXP (~$14.5M) as 10% Owner. The recent filings there lean toward selling, a net 1,467,883 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 30, 2022 | NRXP Nrx Pharmaceuticals, Inc. | 10% Owner | Sell | 22,171 | $1.50 | $33,351.62 | -0.2% | -29.2% | -76.1% | |
| Nov 17, 2022 | NRXP Nrx Pharmaceuticals, Inc. | 10% Owner | Sell | 166,737 | $1.03 | $171,138.22 | -1.7% | -12.3% | -74.6% | |
| Nov 11, 2022 | NRXP Nrx Pharmaceuticals, Inc. | 10% Owner | Sell | 49,200 | $1.01 | $49,509.96 | -0.5% | +13.0% | -67.0% | |
| Jul 29, 2022 | NRXP Nrx Pharmaceuticals, Inc. | 10% Owner | Sell | 784,063 | $1.01 | $791,433.19 | -7.4% | -0.4% | -55.1% | |
| Jun 7, 2022 | NRXP Nrx Pharmaceuticals, Inc. | 10% Owner | Sell | 445,712 | $0.68 | $303,909.59 | -3.4% | +1.6% | -19.2% |